Immunité et cancer : N. Bonnefoy

Liste des Publications

Pinjusic K, Dubey O, Egorova O, Nassiri S, Meylan E, Faget J, Constam D Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma. J Immunother Cancer. 2022;10(5):e004533. doi:10.1136/jitc-2022-004533

Faget J, Peters S, Quantin X, Meylan E, Bonnefoy N Neutrophils in the era of immune checkpoint blockade. J Immunother Cancer. 2021;9(7):e002242. doi:10.1136/jitc-2020-002242

Lafont V, Lucas S, Bonnefoy N Editorial: Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms. Front Immunol. 2021;12. doi:10.3389/fimmu.2021.691899

Boissière-Michot F, Chabab G, Mollevi C, Guiu S, Lopez-Crapez E, Ramos J, Bonnefoy N, Lafont V, Jacot W Clinicopathological Correlates of ?? T Cell Infiltration in Triple-Negative Breast Cancer. Cancers (Basel). 2021;13(4):765. doi:10.3390/cancers13040765

Gros L, Paturel C, Perrot I, Bensussan A, Eliaou J-F, Bastid J, Bonnefoy N [A new generation of immunotherapies targeting the CD39/CD73/adenosine pathway to promote the anti-tumor immune response]. Med Sci (Paris). 2020;36(2):112-115. doi:10.1051/medsci/2020006

Pichard A, Marcatili S, Karam J, Constanzo J, Ladjohounlou R, Courteau A, Jarlier M, Bonnefoy N, Patzke S, Stenberg V, Coopman P, Cartron G, Navarro-Teulon I, Repetto-Llamazares A, Heyerdahl H, Dahle J, Bardiès M, Pouget J-P The therapeutic effectiveness of 177Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest. Leukemia. 2020;34(5):1315-1328. doi:10.1038/s41375-019-0677-4

Bastid J, Dejou C, Docquier A, Bonnefoy N The Emerging Role of the IL-17B/IL-17RB Pathway in Cancer. Front Immunol. 2020;11. doi:10.3389/fimmu.2020.00718

Chabab G, Barjon C, Bonnefoy N, Lafont V Pro-tumor ?? T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for Therapy. Front Immunol. 2020;11. doi:10.3389/fimmu.2020.02186

Chabab G, Bonnefoy N, Lafont V IL-21 Signaling in the Tumor Microenvironment. Adv. Exp. Med. Biol.. 2020;1240. doi:10.1007/978-3-030-38315-2_6

Chabab G, Barjon C, Abdellaoui N, Salvador-Prince L, Dejou C, Michaud H-A, Boissière-Michot F, Lopez-Crapez E, Jacot W, Pourquier D, Bonnefoy N, Lafont V Identification of a regulatory V?1 gamma delta T cell subpopulation expressing CD73 in human breast cancer. J. Leukoc. Biol.. 2020;107(6):1057-1067. doi:10.1002/JLB.3MA0420-278RR

Bourillon L, Demontoy S, Lenglet A, Zampieri A, Fraisse J, Jarlier M, Boissière-Michot F, Perrochia H, Rathat G, Garambois V, Bonnefoy N, Michaud H-A, Chardès T, Tosi D, Pèlegrin A, Azria D, Larbouret C, Bourgier C Higher Anti-Tumor Efficacy of the Dual HER3-EGFR Antibody MEHD7945a Combined with Ionizing Irradiation in Cervical Cancer Cells. Int. J. Radiat. Oncol. Biol. Phys.. 2020;106(5):1039-1051. doi:10.1016/j.ijrobp.2019.12.020

Aroua N, Boet E, Ghisi M, Nicolau-Travers M-L, Saland E, Gwilliam R, de Toni F, Hosseini M, Mouchel P-L, Farge T, Bosc C, Stuani L, Sabatier M, Mazed F, Jarrou L, Gandarillas S, Bardotti M, Picard M, Syrykh C, Laurent C, Gotanegre M, Bonnefoy N, Bellvert F, Portais J-C, Nicot N, Azuaje F, Kaoma T, Joffre C, Tamburini J, Sarry J-E Extracellular ATP and CD39 activate cAMP-mediated mitochondrial stress response to promote cytarabine resistance in acute myeloid leukemia. Cancer Discov. Jul 08, 2020. doi:10.1158/2159-8290.CD-19-1008

Chabab G, Boissière-Michot F, Mollevi C, Ramos J, Lopez-Crapez E, Colombo P-E, Jacot W, Bonnefoy N, Lafont V Diversity of Tumor-Infiltrating, ?? T-Cell Abundance in Solid Cancers. Cells. 2020;9(6). doi:10.3390/cells9061537

Bonnefoy N, Olive D, Vanhove B [Next generation of anti-immune checkpoints antibodies]. Med Sci (Paris). 2019;35(12):966-974. doi:10.1051/medsci/2019193

Deligne C, Gros L [Anti-tumor monoclonal antibodies: new insights to elicit a long-term immune response]. Med Sci (Paris). 2019;35(12):982-989. doi:10.1051/medsci/2019194

Prunaretty J, Boisselier P, Riou O, Simeon S, Bedos L, Azria D, Fenoglietto P Tracking, gating, free-breathing, which technique to use for lung stereotactic treatments? A dosimetric comparison. Rep Pract Oncol Radiother. 2019;24(1):97-104. doi:10.1016/j.rpor.2018.11.003

Andrade A, Tosi D, Michaud H-A, Coquel F, Desigaud D, Jarlier M, Coquelle A, Pasero P, Bonnefoy N, Martineau P, Del Rio M, Beijersbergen R, Vezzio-Vie N Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related (ATR) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer. Cancer Res.. 2019;79(11):2933-2946. doi:10.1158/0008-5472.CAN-18-2807

Ashraf Y, Mansouri H, Laurent-Matha V, Alcaraz L, Roger P, Guiu S, Derocq D, Robin G, Michaud H-A, Jarlier M, Pugnière M, Robert B, Puel A, Martin L, Landomiel F, Bourquard T, Achour O, Fruitier-Arnaudin I, Pichard A, Deshayes E, Turtoi A, Poupon A, Boissière-Michot F, Pirot N, Bernex F, Jacot W, du Manoir S, Theillet C, Pouget J-P, Navarro-Teulon I, Bonnefoy N, Pèlegrin A, Chardès T, Martineau P, Liaudet-Coopman E Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies. J Immunother Cancer. 2019;7(1):29. doi:10.1186/s40425-019-0498-z

Perrot I, Michaud H-A, Giraudon-Paoli M, Augier S, Docquier A, Gros L, Courtois R, Jecko D, Becquart O, Rispaud-Blanc H, Gauthier L, Rossi B, Chanteux S, Gourdin N, Amigues B, Roussel A, Bensussan A, Eliaou J-F, Bastid J, Romagné F, Morel Y, Narni-Mancinelli E, Vivier E, Paturel C, Bonnefoy N Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies. Cell Rep. 2019;27(8):2411-2425.e9. doi:10.1016/j.celrep.2019.04.091

Groeneveld S, Faget J, Zangger N, Meylan E Snail mediates repression of the Dlk1-Dio3 locus in lung tumor-infiltrating immune cells. Oncotarget. 2018;9(64):32331-32345. doi:10.18632/oncotarget.25965

Faget J, Contat C, Zangger N, Peters S, Meylan E RANKL Signaling Sustains Primary Tumor Growth in Genetically Engineered Mouse Models of Lung Adenocarcinoma. J Thorac Oncol. 2018;13(3):387-398. doi:10.1016/j.jtho.2017.11.121

Lauche O, Castan F, de Forges H, Guillaumon C, Gourgou S, Fenoglietto P, Azria D, Riou O Prospective medical analysis of radiation therapist image repositioning during image-guided radiotherapy. Cancer Radiother. 2018;22(1):25-30. doi:10.1016/j.canrad.2017.07.048

Jacqueline C, Bonnefoy N, Charrière G, Thomas F, Roche B Personal history of infections and immunotherapy: Unexpected links and possible therapeutic opportunities. Oncoimmunology. 2018;7(8):e1466019. doi:10.1080/2162402X.2018.1466019

Durand M, Dubois F, Dejou C, Durand E, Danger R, Chesneau M, Brosseau C, Guerif P, Soulillou J-P, Degauque N, Eliaou J-F, Giral M, Bonnefoy N, Brouard S Increased degradation of ATP is driven by memory regulatory T cells in kidney transplantation tolerance. Kidney Int.. 2018;93(5):1154-1164. doi:10.1016/j.kint.2017.12.004

Bourgier C, Castan F, Riou O, Nguyen T-D, Peignaux K, Lemanski C, Lagrange J-L, Kirova Y, Lartigau E, Belkacemi Y, Rivera S, Noël G, Clippe S, Mornex F, Hennequin C, Gourgou S, Brengues M, Fenoglietto P, Ozsahin E, Azria D Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial. Oncotarget. 2018;9(21):15757-15765. doi:10.18632/oncotarget.24606

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés